Detail akcie Becton Dickinson online

Business Summary: Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
Financial Summary: BRIEF: For the three months ended 31 December 2025, Becton Dickinson and Co revenues increased 2% to $5.25B. Net income increased 26% to $382M. Revenues reflect United States segment increase of 3% to $3.16B, International segment remaining flat at $2.09B. Net income benefited from Interventional segment income increase of 45% to $561M, Medical segment income increase of 16% to $569M. Dividend per share increased from $1.04 to $1.05.